NPS PHARMACEUTICALS INC 4/A
4/A · NPS PHARMACEUTICALS INC · Filed Sep 16, 2003
Insider Transaction Report
Form 4/AAmended
STILLER CALVIN
Director
Transactions
- Sale
Common Stock
2003-09-11$32.00/sh−24,000$768,000→ 195,043 total(indirect: Canadian Medical Discoveries Fund Inc.) - Sale
Common Stock
2003-09-09$32.00/sh−20,000$640,000→ 219,043 total(indirect: Canadian Medical Discoveries Fund Inc.)
Holdings
- 4,200
Common Stock
Footnotes (2)
- [F1]This transaction was executed under a Rule 10b5-1 trading plan.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of the person's pecuniary interest in the securities, if any.